Catalyst Wire Dossier Catalyst Wire Dossier

insulin aspart formulation B

insulin aspart · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for insulin aspart formulation B, covering 2017-03-01 to 2017-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Two Insulin Aspart Formulations in Healthy Volunteers [Phase 1]

See pricing